Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy.
Expanding the Clinical Indications for Alpha-1-Antitrypsin Therapy.
Recommendations for the detection and therapeutic management of cognitive impairment in multiple sclerosis.
Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients.
Differences In Multiple Sclerosis Relapse Rates Based On Patient Adherence, Average Daily Dose, And Persistence With Disease-Modifying Therapy: Observations Based on Real-World Data.
Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal study.
Oral BG-12 in multiple sclerosis.
Targeting intracerebral inflammation in multiple sclerosis: is it feasible?
Setting new standards in multiple sclerosis care and research.
CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.
Brain circuitry outside the synaptic cleft.
Averting inflammation by targeting the cytokine environment.
Phase IIa laquinimod trial results show positive data for potential use in active Crohn's disease
Extracting quantitative measures from EAP: a small clinical study using BFOR.
Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome.
The Puerto Rico study for the prevalence of Multiple Sclerosis.
Experimental RRMS Therapy to Be Tested in a Phase 2b Clinical Trial
Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis.
Pediatric Multiple Sclerosis.
Multiple sclerosis and the spinal cord.
Exosomes as a potential novel therapeutic tools against neurodegenerative diseases.
Signaling and Regulatory Functions of Bioactive Sphingolipids as Therapeutic Targets in Multiple Sclerosis.
Therapeutic Armamentarium and Health System Coverage of Multiple Sclerosis in Latin America.
Reversible blindness in bilateral optic neruritis associated with nasal flu vaccine.

Pages